Continuous Glucose Monitors: Market Size & Forecast 2026

The global continuous glucose monitor (CGM) market reached approximately USD 5.8 billion in 2025, held in a structurally concentrated position between a duopoly of Abbott and Dexcom, accelerating Medicare and Medicaid reimbursement expansion, and the first wave of over-the-counter (OTC) approvals that are redrawing the addressable population beyond diagnosed diabetes. The base year price band for factory-calibrated real-time CGM sensors runs USD 35-45 per unit at reference volumes, with user-calibrated intermittently scanned variants at a USD 20-30 discount. We project a 7-year CAGR of 13.5 percent through 2032, reaching roughly USD 14 billion at forecast year end, a trajectory that assumes sustained reimbursement growth and OTC category development, both of which carry material execution risk. > **Analyst Take.** The call is not to chase the 13.5 percent consensus CAGR; the number is di

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.